CD30 expression identifies the predominant proliferating T lymphocyte population in human alloimmune responses

被引:36
作者
Chan, KW
Hopke, CD
Krams, SM
Martinez, OM
机构
[1] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA
关键词
D O I
10.4049/jimmunol.169.4.1784
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD30 is an inducible member of the TNFR superfamily that is expressed on activated T and B cells and some lymphoid malignancies. We have previously shown that human CD30(+) T cells elicited with allogeneic APC are a major source of IFN-gamma and IL-5 production. In the present study we have used alloantigen, as well as anti-CD3 plus anti-CD28 mAb stimulation, to further characterize human CD30(+) T cells with respect to function and the expression of other activation-dependent cell surface molecules, including the related TNFR family members OX-40 and 4-1BB (CD137). Our results indicate that human CD30(+) T cells are a subset of activated T cells that also express CD25 and CD45RO. Moreover, we observed that allogeneic APC consistently induced a greater proportion of CD30+ cells within the activated T cell population than did stimulation with plate-bound anti-CD3 plus anti-CD28 mAb or stimulation with soluble anti-CD3 plus anti-CD28 and autologous APC. The enhanced induction of CD30 expression by alloantigen was not common to other inducible TNFR family members because anti-CD3 plus anti-CD28 mAbs were far more effective in inducing expression of 4-IBB and OX-40. Furthermore, CD30 expression marked the predominant proliferating T cell population induced by alloantigen as determined by USE staining and flow cytometry. These results indicate that CD30, but not 4-1BB or OX-40, is preferentially induced by alloantigen, suggesting that CD30 may be important in human alloimmune responses.
引用
收藏
页码:1784 / 1791
页数:8
相关论文
共 40 条
[1]   Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis [J].
Akiba, H ;
Miyahira, Y ;
Atsuta, M ;
Takeda, K ;
Nohara, C ;
Futagawa, T ;
Matsuda, H ;
Aoki, T ;
Yagita, H ;
Okumura, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (02) :375-380
[2]  
ALZONA M, 1994, J IMMUNOL, V153, P2861
[3]   Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice [J].
Amakawa, R ;
Hakem, A ;
Kundig, TM ;
Matsuyama, T ;
Simard, JJL ;
Timms, E ;
Wakeham, A ;
Mittruecker, HW ;
Griesser, H ;
Takimoto, H ;
Schmits, R ;
Shahinian, A ;
Ohashi, PS ;
Penninger, JM ;
Mak, TW .
CELL, 1996, 84 (04) :551-562
[4]   Opposite role for interleukin-4 and interferon-gamma on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells [J].
Annunziato, F ;
Manetti, R ;
Cosmi, L ;
Galli, G ;
Heusser, CH ;
Romagnani, S ;
Maggi, E .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (09) :2239-2244
[5]   Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation [J].
Bengtsson, A ;
Johansson, C ;
Linder, MT ;
Hallden, G ;
vanderPloeg, I ;
Scheynius, A .
JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 58 (06) :683-689
[6]  
BISWAS P, 1995, IMMUNITY, V2, P587
[7]  
BROWN GR, 1995, J IMMUNOL, V154, P3686
[8]   4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy [J].
Cannons, JL ;
Lau, P ;
Ghumman, B ;
DeBenedette, MA ;
Yagita, H ;
Okumura, K ;
Watts, TH .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1313-1324
[9]  
Chiarle R, 1999, J IMMUNOL, V163, P194
[10]  
DeBenedette MA, 1999, J IMMUNOL, V163, P4833